Safety and immunogenicity of a live attenuated mumps vaccine A phase I clinical trial

Yan Liang; Jingchen Ma; Changgui Li; Yuguo Chen; Longding Liu; Yun Liao; Ying Zhang; Li Jiang; Xuanyi Wang; Yanchun Che; Wei Deng; Hong Li; Xiaoyu Cui; Na Ma; Dong Ding; Zhongping Xie; Pingfang Cui; Qiuyan JP

首页> 外文期刊>Human vaccines >Safety and immunogenicity of a live attenuated mumps vaccine A phase I clinical trial

【24h】

Safety and immunogenicity of a live attenuated mumps vaccine A phase I clinical trial

机译：减毒腮腺炎活疫苗A期临床试验的安全性和免疫原性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Mumps, a communicable, acute and previously well-controlled disease, has had recent and occasional resurgences in some areas.Methods; A randomized, double-blind, controlled and multistep phase I study of an F-genotype attenuated mumps vaccine produced in human diploid cells was conducted. A total of 300 subjects were enrolled and divided into 4 age groups: 16-60 years, 5-16 years, 2-5 years and 8-24 months.

机译：背景：流行性腮腺炎是一种传染性，急性和先前得到良好控制的疾病，最近在某些地区出现了偶发性复发。对人二倍体细胞中产生的F基因型减毒腮腺炎疫苗进行了随机，双盲，对照和多步I期研究。共有300名受试者入选，分为4个年龄段：16-60岁，5-16岁，2-5岁和8-24个月。

著录项

来源
《Human vaccines》 |2014年第5期|共9页
作者
Yan Liang; Jingchen Ma; Changgui Li; Yuguo Chen; Longding Liu; Yun Liao; Ying Zhang; Li Jiang; Xuanyi Wang; Yanchun Che; Wei Deng; Hong Li; Xiaoyu Cui; Na Ma; Dong Ding; Zhongping Xie; Pingfang Cui; Qiuyan JP;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
F genotype attenuated mumps vaccine; Phase I clinical trial; safety; immunogenicity;

机译：F基因减毒腮腺炎疫苗;I期临床试验;安全性;免疫原性;

相似文献

外文文献
中文文献
专利

1. Safety and immunogenicity of a live attenuated mumps vaccine A phase I clinical trial [J] . Yan Liang, Jingchen Ma, Changgui Li, Human vaccines . 2014,第5期

机译：减毒腮腺炎活疫苗A期临床试验的安全性和免疫原性
2. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial [J] . Sood Ashwani, Mitra Monjori, Joshi Himanshu Arvind, Human vaccines & immunotherapeutics. . 2017,第7期

机译：含有edmonston-Zagreb麻疹菌株，霍尼诺腮腺炎菌株的新型MMR疫苗（活性，冷冻干燥）的免疫原性和安全性，以及RA 27/3风疹菌株：随机化，比较，活性受控期III临床试验结果
3. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC (R) in comparison with a licensed rotavirus vaccine in healthy infants [J] . Vaccine . 2019,第31期

机译：随机开放标记的非劣级阶段4临床试验，以评估活性，减毒，口服轮状病毒疫苗，Rotavac（R）的免疫原性和安全性与健康婴儿的持牌轮状病毒疫苗相比
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Phase I clinical trial of a chlorhexidine diacetate intraoral delivery system in medically healthy gingivitis subjects. [D] . Van Scoyoc, Steven M. 2008

机译：在医学上健康的牙龈炎患者中，双乙酸洗必泰口服系统的I期临床试验。
6. Immunogenicity and safety of concurrent or sequential administration of live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial [O] . Maria Rosario Capeding, Edison Alberto, Jodi Feser, 2020

机译：直播或连续施用的免疫原性和安全性衰减SA 14-14-2日本脑炎疫苗（CD-JEV）和婴儿9-12个月的麻疹-Mumps-Surbella疫苗：非劣势阶段4随机临床试验
7. Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen [O] . Thomas P. Monath, Farshad Guirakhoo, Richard Nichols, 2003

机译：嵌合活，抗日脑炎的减毒疫苗（Chimerivax-JE）：2期临床试验，用于安全性和免疫原性，疫苗剂量和时间表的影响，以及记忆响应犯罪的灭火症抗原

Safety and immunogenicity of a live attenuated mumps vaccine A phase I clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅